Molecular Mechanism of Vine Tea Dihydromyricetin Extract on Alleviating Glucolipid Metabolism Disorder in db/db Mice: Based on Liver RNA-Seq and TLR4/MyD88/NF-κB Pathway
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26052169 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xixin Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China. Hauptthemen laut MEDLINE: Liver, Flavonols, Plant Extracts, Tea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan Natural Science Foundation, Changsha Natural Science Foundation, National Key Research and Development Program of China.
Abstract (Originalsprache)
The primary active compound in vine tea is dihydromyricetin (DMY), which has a longstanding history as a dietary supplement and traditional ethnic medicine. However, the precise molecular mechanism by which vine tea dihydromyricetin extract (VDMY) regulates glucolipid metabolic disorder remains unclear. In this study, we first assessed the effect of VDMY on various physiological parameters in db/db mice, followed by RNA sequencing (RNA-seq) to identify key signaling pathways affected by VDMY in liver tissues. We also examined the impact of VDMY on the liver’s TLR4/MyD88/NF-κB and FOXO1 pathways using Western blotting. Our results showed that VDMY significantly reduced fasting blood glucose (FBG), total cholesterol (TC), triglycerides (TGs), and low-density lipoprotein cholesterol (LDL-C), while increasing high-density lipoprotein cholesterol (HDL-C) levels. Additionally, VDMY enhanced the liver’s antioxidant capacity by upregulating superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH), while lowering malondialdehyde (MDA), alanine aminotransferase (ALT), and aspartate aminotransferase (AST), thus alleviating liver damage. RNA-seq analysis further revealed that VDMY influenced multiple biological processes, including transcription, glycolysis, gluconeogenesis, and redox reactions, suggesting that its effects may be mediated through the TLR4/MyD88/NF-κB and FOXO1 pathways. Additionally, Western blot analysis revealed that VDMY effectively downregulated the expressions of TLR4, MyD88, NF-κB, and FOXO1 proteins in the liver of db/db mice, indicating that VDMY could target these pathways to intervene glucolipid metabolism dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.
- College of Food Science and Technology, Hunan Agricultural University, Changsha 410128, China.
- Xiangya School of Basic Medical Sciences, Central South University, Changsha 410013, China.
ORCID-Profile: Chenghao Lv, Si Qin
Förderung
- Hunan Natural Science Foundation
- Changsha Natural Science Foundation
- National Key Research and Development Program of China
Zitieren
APA
Zhou, X., Liu, X., Yi, Y., Chen, S., Zhang, Y., Fan, W., Lv, C., & Qin, S. (2025). Molecular Mechanism of Vine Tea Dihydromyricetin Extract on Alleviating Glucolipid Metabolism Disorder in db/db Mice: Based on Liver RNA-Seq and TLR4/MyD88/NF-κB Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26052169
Vancouver
Zhou X, Liu X, Yi Y, Chen S, Zhang Y, Fan W, et al. Molecular Mechanism of Vine Tea Dihydromyricetin Extract on Alleviating Glucolipid Metabolism Disorder in db/db Mice: Based on Liver RNA-Seq and TLR4/MyD88/NF-κB Pathway. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26052169
BibTeX
@article{Zhou2025,
author = {Zhou, Xixin and Liu, Xin and Yi, Yuhang and Chen, Shiyun and Zhang, Yi and Fan, Wei and Lv, Chenghao and Qin, Si},
title = {Molecular Mechanism of Vine Tea Dihydromyricetin Extract on Alleviating Glucolipid Metabolism Disorder in db/db Mice: Based on Liver RNA-Seq and TLR4/MyD88/NF-κB Pathway},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26052169}
}
EUVIMED